Evercore Wealth Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-41,841
| Closed | -$626K | – | 419 |
|
|
2022
Q4 | $626K | Hold |
41,841
| – | – | 0.01% | 253 |
|
|
2022
Q3 | $344K | Hold |
41,841
| – | – | 0.01% | 295 |
|
|
2022
Q2 | $274K | Hold |
41,841
| – | – | 0.01% | 330 |
|
|
2022
Q1 | $234K | Hold |
41,841
| – | – | ﹤0.01% | 396 |
|
|
2021
Q4 | $196K | Hold |
41,841
| – | – | ﹤0.01% | 414 |
|
|
2021
Q3 | $259K | Buy |
41,841
+498
| +1% | +$2.98K | ﹤0.01% | 385 |
|
|
2021
Q2 | $272K | Sell |
41,343
-4,984
| -11% | -$34.4K | 0.01% | 382 |
|
|
2021
Q1 | $339K | Hold |
46,327
| – | – | 0.01% | 346 |
|
|
2020
Q4 | $268K | Buy |
46,327
+4,984
| +12% | +$28.5K | 0.01% | 378 |
|
|
2020
Q3 | $246K | Hold |
41,343
| – | – | 0.01% | 336 |
|
|
2020
Q2 | $213K | Hold |
41,343
| – | – | 0.01% | 356 |
|
|
2020
Q1 | $150K | Sell |
41,343
-498
| -1% | -$2.47K | ﹤0.01% | 348 |
|
|
2019
Q4 | $261K | Hold |
41,841
| – | – | 0.01% | 356 |
|
|
2019
Q3 | $353K | Hold |
41,841
| – | – | 0.01% | 312 |
|
|
2019
Q2 | $282K | Hold |
41,841
| – | – | 0.01% | 350 |
|
|
2019
Q1 | $343K | Hold |
41,841
| – | – | 0.01% | 314 |
|
|
2018
Q4 | $669K | Hold |
41,841
| – | – | 0.03% | 223 |
|
|
2018
Q3 | $1.39M | Hold |
41,841
| – | – | 0.04% | 173 |
|
|
2018
Q2 | $946K | Hold |
41,841
| – | – | 0.03% | 207 |
|
|
2018
Q1 | $1.21M | Hold |
41,841
| – | – | 0.05% | 170 |
|
|
2017
Q4 | $1.17M | Buy |
41,841
+25,000
| +148% | +$776K | 0.04% | 175 |
|
|
2017
Q3 | $615K | Hold |
16,841
| – | – | 0.02% | 228 |
|
|
2017
Q2 | $374K | Hold |
16,841
| – | – | 0.01% | 293 |
|
|
2017
Q1 | $99K | Buy |
16,841
+12,953
| +333% | +$93.6K | ﹤0.01% | 488 |
|
|
2016
Q4 | $21K | Hold |
3,888
| – | – | ﹤0.01% | 749 |
|
|
2016
Q3 | $35K | Hold |
3,888
| – | – | ﹤0.01% | 676 |
|
|
2016
Q2 | $37K | Hold |
3,888
| – | – | ﹤0.01% | 641 |
|
|
2016
Q1 | $36K | Hold |
3,888
| – | – | ﹤0.01% | 632 |
|
|
2015
Q4 | $49K | Hold |
3,888
| – | – | ﹤0.01% | 604 |
|
|
2015
Q3 | $47K | Hold |
3,888
| – | – | ﹤0.01% | 594 |
|
|
2015
Q2 | $68K | Hold |
3,888
| – | – | ﹤0.01% | 587 |
|
|
2015
Q1 | $56K | Buy |
3,888
+742
| +24% | +$8.11K | ﹤0.01% | 609 |
|
|
2014
Q4 | $27K | Buy |
3,146
+631
| +25% | +$5.77K | ﹤0.01% | 628 |
|
|
2014
Q3 | $28K | Buy |
2,515
+390
| +18% | +$4.96K | ﹤0.01% | 690 |
|
|
2014
Q2 | $39K | Buy |
2,125
+848
| +66% | +$11K | ﹤0.01% | 646 |
|
|
2014
Q1 | $19K | Hold |
1,277
| – | – | ﹤0.01% | 751 |
|
|
2013
Q4 | $23K | Buy |
1,277
+719
| +129% | +$14.4K | ﹤0.01% | 662 |
|
|
2013
Q3 | $11K | Hold |
558
| – | – | ﹤0.01% | 748 |
|
|
2013
Q2 | $14K | Buy |
+558
| New | +$23.9K | ﹤0.01% | 697 |
|
Evercore Wealth Management's AVEO Position: Q1 2023 in Review
Evercore Wealth Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 41,841 shares — an estimated $626K sold.
Evercore Wealth Management first reported a position in AVEO in Q2 2013 and held it in 39 quarters. The position peaked at $1.39M in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Evercore Wealth Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Evercore Wealth Management sold 41,841 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $626K.
- Evercore Wealth Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 39 quarters.
- Evercore Wealth Management's AVEO Pharmaceuticals, Inc. position peaked at $1.39M in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Evercore Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.